REBECCA SEXTON: Open Payments
NPI 1336829027 · JEFFERSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 46 payments from 20 companies in 2025. Trend: 2023 $381 · 2024 $1,624 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $143 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Novo Nordisk Inc | 3 | $70 |
| HEARTFLOW, INC. | 1 | $63 |
| Astellas Pharma US Inc | 2 | $55 |
| PFIZER INC. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Tandem Diabetes Care, Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
Products named: Ozempic, AIRSUPRA, FFRct, UBRELVY, Veozah, CAPLYTA, t:slim X2 Insulin Pump with Control-IQ, XIFAXAN.
Industry payments across TN — which companies pay providers there.
